A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers.
Clinical trial NCT05407220 · COMPLETED
Trial details
- NCT number
- NCT05407220
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2022-07-25
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.